These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19010866)

  • 21. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism.
    Gu Z; Yamashiro J; Kono E; Reiter RE
    Cancer Res; 2005 Oct; 65(20):9495-500. PubMed ID: 16230414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer.
    Yu S; Feng F; Wang K; Men C; Lin C; Liu Q; Yang D; Gao Z
    Eur J Med Res; 2013 Dec; 18(1):56. PubMed ID: 24330823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
    Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer.
    Chu X; Shin S; Baek DS; Zhang L; Conard A; Shi M; Kim YJ; Adams C; Hines M; Liu X; Chen C; Sun Z; Jelev DV; Mellors JW; Dimitrov DS; Li W
    MAbs; 2024; 16(1):2387240. PubMed ID: 39113562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer.
    Foss CA; Mease RC; Fan H; Wang Y; Ravert HT; Dannals RF; Olszewski RT; Heston WD; Kozikowski AP; Pomper MG
    Clin Cancer Res; 2005 Jun; 11(11):4022-8. PubMed ID: 15930336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
    Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
    Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
    Kenanova V; Olafsen T; Crow DM; Sundaresan G; Subbarayan M; Carter NH; Ikle DN; Yazaki PJ; Chatziioannou AF; Gambhir SS; Williams LE; Shively JE; Colcher D; Raubitschek AA; Wu AM
    Cancer Res; 2005 Jan; 65(2):622-31. PubMed ID: 15695407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
    Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
    Dong L; Zhang X; Ren J; Wu S; Yu T; Hou L; Fu L; Yi S; Yu C
    Cancer Biother Radiopharm; 2013 Jun; 28(5):391-7. PubMed ID: 23701419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer targeting motifs: expression of αν β3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.
    Taylor RM; Severns V; Brown DC; Bisoffi M; Sillerud LO
    Prostate; 2012 Apr; 72(5):523-32. PubMed ID: 21748756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
    Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
    Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution.
    Tolmachev V; Malmberg J; Estrada S; Eriksson O; Orlova A
    Int J Oncol; 2014 Jun; 44(6):1998-2008. PubMed ID: 24718894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.
    Olafsen T; Betting D; Kenanova VE; Salazar FB; Clarke P; Said J; Raubitschek AA; Timmerman JM; Wu AM
    J Nucl Med; 2009 Sep; 50(9):1500-8. PubMed ID: 19690034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
    Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
    PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.